Two Executives Out at Johnson & Johnson
Two executives in Johnson & Johnson’s recall-riddled consumer products business are departing in two months.
The longtime executives are leaving after a 2 1/2-year span that’s seen two dozen recalls of Tylenol and other nonprescription drugs and a congressional investigation of the handling of the recalls. Federal regulators are now overseeing three factories that made those products, one of which has been shut for nearly two years.
Johnson & Johnson says Patrick Mutchler, group chairman for over-the-counter drugs, nutritionals and wellness and prevention products, is retiring after 35 years with the health care giant.
Pericles Stamatiades, who headed global strategy for other consumer businesses, is leaving after 28 years at J&J.
(Copyright 2012 by The Associated Press. All Rights Reserved.)